Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ  e900. Doi: 10.1136/bmj.e900.

Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology 23:6-12.

Bansal N, Wright JD, Cohen CJ, Herzog TJ (2008). Natural history of established low-grade cervical intraepithelial (CIN1) lesions. Anticancer Res 28:1763-6.

Bray F, Carstensen B, Moller H et al. (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer epidemiol Biomarkers Prev 14:2191-9.

Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ (2005). Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113:1005-0.

Carozzi FM, Tomesello ML, Burroni E et al. (2010). Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 19:2389-400.

Castle PE, Schiffman M, Wheeler CM, Solomon D (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 113:18-25.

Darragh TM, Colgan TJ, Cox JT et al. (2012). The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arc Pathol Lab Med 136:1266-97.

de Sanjose S, Quint WGV, Alemany L et al. (2010) Human papillomvirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey. Lancet Oncol 11:1048-56.

Galgano MT, Castle PE, Atkins KA et al. (2010). Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 3:1077-87.

Gustafsson L, Adami HO (1989). Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 60:132-41.

Herbert A, Anshu, Culora G et al. (2010). Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme. Br J Obstet Gynaecol 117:736-45.

Holowaty P, Miller AB, Rohan T, To T (1999). Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252-8.

Jaisamrarn U, Castellsague X, Garland SM et al. (2013). Natural history of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One 8:e79260.

Jordan J, Arbyn M, Martin-Hirsch P et al. (2008) European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology. Cytopathology 19:342-54.

Kelloff GJ, Sigman CC (2007). Assessing intraepithelial neoplasia and drug safety in cancer-preventative drug development. Nature Reviews Cancer 7:508-18.

McCredie MR, Sharples KJ, Baranyai J et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial  neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425-34.

Ostör AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol  12:186-92.

Ostör AG, Duncan A, Quinn M, Rome R (2000). Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 79:207-10.

Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-56.

Prendiville W (2009). The treatment of CIN: what are the risks? Cytopathology 20:145-53.

Sasieni P, Castanon A, Cuzick J (2009). Screening and adenocarcinoma. Int J Cancer 125:525-9.

Stoler MH, Schiffman M (2001). Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285:1500-5.

Talaat A, Brinkmann D, Dhundee J et al. (2012).  Risk of significant gynaecological pathology in women with ?glandular neoplasia on cervical cytology.  Cytopathology 23:371-7.

Viczaino AP, Moreno V, Bosch FX (1998). International trends in the incidence of cervical cancer: adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75:536-45.

WHO (2015). World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC 2015. Available from

Woodman CJ, Collins C, Rollason TP et al. (2003). Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia.  Lancet 2003;361:40-3.